Composition for preventing or treating cervical cancer having human papillomavirus plasmodium and immunity enhancer
AssigneeGenexine, Inc.
InventorsYoung Chul Sung, Sang Hwan Seo, You Suk Suh
Life of this patent
Estimating the term…
Abstract
A composition for preventing or treating cervical cancer comprising a human papillomavirus plasmodium and an immunity enhancer is provided. A fusion protein including a fusion polypeptide recombined to transform a 3D structure of E6 and E7, which are antigens against types 16 and 18 human papillomavirus (HPV), a signal peptide for secreting the fusion polypeptide outside the cells and an immunity enhancer peptide present in an individual is also provided. The fusion protein may be useful in treating HPV-triggered tumors by inducing an immune response specific to the antigens against the HPV types 16 and 18.
Claims25
A polynucleotide encoding a fusion protein comprising the sequence of SEQ ID NO:1.
Dependencies are inferred from the claim text.